PMID- 23959047 OWN - NLM STAT- MEDLINE DCOM- 20140220 LR - 20220309 IS - 0006-3002 (Print) IS - 0006-3002 (Linking) VI - 1832 IP - 12 DP - 2013 Dec TI - Tumor necrosis factor-alpha-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis. PG - 2136-44 LID - S0925-4439(13)00267-6 [pii] LID - 10.1016/j.bbadis.2013.08.002 [doi] AB - Mesenchymal stem cells (MSCs) accelerate regeneration of ischemic or injured tissues by stimulation of angiogenesis through a paracrine mechanism. Tumor necrosis factor-alpha (TNF-alpha)-activated MSCs secrete pro-angiogenic cytokines, including IL-6 and IL-8. In the present study, using an ischemic hindlimb animal model, we explored the role of IL-6 and IL-8 in the paracrine stimulation of angiogenesis and tissue regeneration by TNF-alpha-activated MSCs. Intramuscular injection of conditioned medium derived from TNF-alpha-treated MSCs (TNF-alpha CM) into the ischemic hindlimb resulted in attenuated severe limb loss and stimulated blood perfusion and angiogenesis in the ischemic limb. Immunodepletion of IL-6 and IL-8 resulted in attenuated TNF-alpha CM-stimulated tissue repair, blood perfusion, and angiogenesis. In addition, TNF-alpha CM induced migration of human cord blood-derived endothelial progenitor cells (EPCs) through IL-6- and IL-8-dependent mechanisms in vitro. Intramuscular injection of TNF-alpha CM into the ischemic limb led to augmented homing of tail vein-injected EPCs into the ischemic limb in vivo and immunodepletion of IL-6 or IL-8 from TNF-alpha CM attenuated TNF-alpha CM-stimulated homing of EPCs. In addition, intramuscular injection of recombinant IL-6 and IL-8 proteins resulted in increased homing of intravenously transplanted EPCs into the ischemic limb and improved blood perfusion in vivo. These results suggest that TNF-alpha CM stimulates angiogenesis and tissue repair through an increase in homing of EPCs through paracrine mechanisms involving IL-6 and IL-8. CI - (c) 2013. FAU - Kwon, Yang Woo AU - Kwon YW AD - Medical Research Center for Ischemic Tissue Regeneration, School of Medicine, Pusan National University, Yangsan, Republic of Korea; Department of Physiology, School of Medicine, Pusan National University, Yangsan, Republic of Korea. FAU - Heo, Soon Chul AU - Heo SC FAU - Jeong, Geun Ok AU - Jeong GO FAU - Yoon, Jung Won AU - Yoon JW FAU - Mo, Won Min AU - Mo WM FAU - Lee, Mi Jeong AU - Lee MJ FAU - Jang, Il-Ho AU - Jang IH FAU - Kwon, Sang Mo AU - Kwon SM FAU - Lee, Jung Sub AU - Lee JS FAU - Kim, Jae Ho AU - Kim JH LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130816 PL - Netherlands TA - Biochim Biophys Acta JT - Biochimica et biophysica acta JID - 0217513 RN - 0 (Culture Media, Conditioned) RN - 0 (Interleukin-6) RN - 0 (Interleukin-8) RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Adipocytes/cytology/drug effects/metabolism MH - Animals MH - Blotting, Western MH - *Cell Movement MH - Cell Proliferation MH - Cells, Cultured MH - Culture Media, Conditioned/*pharmacology MH - Fluorescent Antibody Technique MH - Hindlimb/*blood supply/metabolism/pathology MH - Human Umbilical Vein Endothelial Cells/*cytology/drug effects/metabolism MH - Humans MH - Interleukin-6/deficiency/immunology MH - Interleukin-8/deficiency/immunology MH - Ischemia/*drug therapy/metabolism/pathology MH - Mesenchymal Stem Cells/*cytology/drug effects/metabolism MH - Mice MH - Mice, Nude MH - Necrosis MH - *Neovascularization, Physiologic MH - Stem Cells/*cytology/drug effects/metabolism MH - Tumor Necrosis Factor-alpha/*pharmacology MH - Wound Healing OTO - NOTNLM OT - Angiogenesis OT - EPCs OT - Endothelial progenitor cells OT - Ischemia OT - MSCs OT - Mesenchymal stem cells OT - TNF-alpha OT - TNF-alpha CM OT - Tumor necrosis factor-alpha OT - conditioned medium derived from TNF-alpha-treated MSCs OT - endothelial progenitor cells OT - hASCs OT - human adipose tissue-derived MSCs OT - mesenchymal stem cells OT - tumor necrosis factor-alpha EDAT- 2013/08/21 06:00 MHDA- 2014/02/22 06:00 CRDT- 2013/08/21 06:00 PHST- 2013/04/02 00:00 [received] PHST- 2013/07/29 00:00 [revised] PHST- 2013/08/11 00:00 [accepted] PHST- 2013/08/21 06:00 [entrez] PHST- 2013/08/21 06:00 [pubmed] PHST- 2014/02/22 06:00 [medline] AID - S0925-4439(13)00267-6 [pii] AID - 10.1016/j.bbadis.2013.08.002 [doi] PST - ppublish SO - Biochim Biophys Acta. 2013 Dec;1832(12):2136-44. doi: 10.1016/j.bbadis.2013.08.002. Epub 2013 Aug 16.